Human Wound Care Program
Acute, chronic, and burn wounds (human)
Pre-clinical/DevelopmentActive
Key Facts
Indication
Acute, chronic, and burn wounds (human)
Phase
Pre-clinical/Development
Status
Active
Company
About Noxsano
Noxsano is a private, commercial-stage company focused on advanced wound care through its proprietary nitric oxide delivery platform. Its initial commercial products, Restore Wound Pads and Gels, are marketed directly to veterinary professionals, demonstrating significant efficacy in accelerating wound healing. The company was founded by seasoned scientists and healthcare professionals with backgrounds at major corporations like Procter & Gamble and is supported by a strong advisory board. Noxsano's technology holds promise for expanding into the larger human wound care market.
View full company profile